Kilitch Drugs (India) share news and announcements
NSE: KILITCHBSE: 524500Pharmaceuticals & BiotechnologySmall Cap
Last close ₹202.24up ₹0.13 (0.06%)BSE ₹203.50
Share price at the NSE close on 23 Oct 2026. Previous close ₹202.11.
52-week range of traded prices to 23 Oct 2026
₹117.25Low, 30 Mar 2026₹267.90High, 7 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹707 Cr1,776th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 23.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 15 May 2026
- 2.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 12.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 8.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 15 May 2026
- 0.32
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,44,52347.0% delivered
Kilitch Drugs (India) board meetings
156 filed, newest first. Page 1 of 4.
Oct 2026
22 Oct · Board meeting
Aug 2026
Jul 2026
28 Jul · Board meeting
May 2026
Mar 2026
25 Mar · Board meeting
Feb 2026
Nov 2025
13 Nov · Board meeting
Aug 2025
25 Aug · Board meeting
Jul 2025
Jun 2025
29 Jun · Board meeting
May 2025
Feb 2025
Nov 2024
Aug 2024
30 Aug · Board meeting
26 Aug · Board meeting
8 Aug · Board meeting
May 2024
27 May · Board meeting
Feb 2024
8 Feb · Board meeting
Jan 2024
Nov 2023
Aug 2023
11 Aug · Board meeting
Jul 2023
29 Jul · Board meeting
22 Jul · Board meeting
May 2023
Mar 2023
15 Mar · Board meeting
Feb 2023
14 Feb · Board meeting
Nov 2022
Aug 2022
May 2022
Feb 2022
Jan 2022
24 Jan · Board meeting
Dec 2021
20 Dec · Board meeting
Nov 2021
12 Nov · Board meeting
Oct 2021
13 Oct · Board meeting
Aug 2021
13 Aug · Board meeting
Jun 2021
22 Jun · Board meeting